There is no standard of care for fibrolamellar liver cancer, no targeted therapies. But that may be changing, thanks to ...

By analysing DNA from blood samples, Tvaster Genkalp is working to make cancer diagnostics more accessible, accurate, and ...

This manuscript characterizes a mutated clone of RNA polymerase I in yeast, referred to as SuperPol, to understand the mechanisms of RNA polymerase I elongation and termination. The authors present ...

Microscopic command centers in our bodies called primary cilia—once thought irrelevant—could be hidden switches powering ...

A study on fasting and the ketogenic diet uncovers a newfound weakness in pancreatic tumors, making them more susceptible to ...

In one model, blocking a specific pathway in the SKP2–p27–CDK2/CDK1 axis stopped cancer from developing. This approach didn’t affect other features of the cells, like their ability to ...

It has also been a focus of researchers developing treatments for cancer by finding ways to activate the cell death of cancer cells themselves. Ferroptosis is a recently discovered form of ...

Scientists from the Keck School of Medicine at University of Southern California have developed a spectral flow ...

Cancer scientists engineer a new type of antibody which could be used to boost the immune systems of patients fighting disease.

It’s the metastases—the cancer cells that break away and spread through the body. These traveling cells leave the original tumor and move into blood vessels or lymph nodes. Once they reach new ...

BUFFALO, N.Y. — University at Buffalo medicinal chemist David Heppner has received the 2025 Philip S. Portoghese Lectureship ...